Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06289959 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Plasma cfDNA Testing Guiding the Treatment Decisions of DLBCL

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
A prospective, single center, randomized, clinical controlled study to evaluate the efficacy and prognosis differences between precision treatment based on plasma cfDNA testing results and the current conventional diagnostic and treatment practices for DLBCL patients.
Trial Details
NCT Number NCT06289959
Lead Sponsor Second Affiliated Hospital of Soochow University
Conditions
(from sponsor)		 Lymphoma, Large B-Cell, Diffuse
Related terms Lymphoma, Large B-Cell, Diffuse
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov